PepDiana
Back to Evidence
Primary experimental recordNegative / threshold

PMC10135057::ACT000382

F-NZ2114

Evidence text

Paper-level observation

Table 3: FNZ MIC against S. aureus ATCC 43300 in Artificial Intestinal Fluid (10 min) >16 μg/mL (>3.5 μM)
tableConfidence: medium

Assay observation

Activity
Antimicrobial
Subtype
Antibacterial
Measure
MIC
Comparator
>
Raw observation
>16 μg/mL
Normalized measurement
>16 µg/mL
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Staphylococcus aureus
Assay method
Not reported by source
Sequence
Not reported by source
Standardization
insufficient information

Source publication

Molecular Modification of Kex2 P1' Site Enhances Expression and Druggability of Fungal Defensin

Antibiotics · 2023

DOI 10.3390/antibiotics12040786 PMC10135057
Parent mention

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.